FDA to Review Capsaicin Patch for Painful Diabetic Peripheral Neuropathy
The FDA has a supplemental New Drug Application for capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy.
Peripheral Neuropathy
Peripheral Neuropathy Common in Childhood Cancer Survivors
Childhood cancer survivors frequently have clinical abnormalities attributable to peripheral neuropathy.
Distinct Mechanisms Underlie Nerve Damage in Peripheral Neuropathy in Type 1 vs Type 2 Diabetes
The type of sciatic nerve lesions observed in patients with diabetic peripheral neuropathy was found to differ in type 1 and type 2 diabetes.
Spinal Cord Stimulation Reduces Pain Associated With Diabetic Polyneuropathy
Chronic pain symptoms in patients with PDPN are effectively reduced with spinal cord stimulation.
Peripheral Neuropathy After Chemotherapy: Mechanism Identified
The mechanism for chemotherapy-induced peripheral neuropathy may have been uncovered.
Sensory Neuropathy Common After Adjuvant Chemotherapy
Chemotherapy-associated chronic pain and neuropathy have substantial impacts on patients’ lives.
Peripheral Neuropathic Pain Treated With Capsaicin 8% Patch
The patch used in the study is approved in the United States for postherpetic neuralgia and in Europe for PNP arising from any etiology.
Prediabetes, Obesity May Impact Risk of Polyneuropathy
Diabetes, waist circumference, and prediabetes were the main metabolic factors associated with neuropathy.
Parkinson’s Intestinal Gel May Cause Nerve Damage
The small study documented several cases of denervation and increased thermal thresholds in patients treated with LCIG.
FDA Fast Tracks Potential Neuropathy Treatment
The designation has been granted to potentially treat neuropathic pain associated with diabetic peripheral neuropathy.
